Zoic Capital

About The Fund

Zoic Capital is a venture capital firm that specializes in funding and nurturing early-stage ventures that operate at the crossroads of Life Sciences and Medical Technology. With its headquarters in Bellevue, Washington, Zoic Capital extends its presence through additional offices in Seattle, San Francisco, Minneapolis, San Antonio, and Tampa. Their investment strategy focuses on seed to Series A financing, emphasizing the initial three rounds of funding to support the progression of frontier science to market viability. The firm underlines four fundamental principles: investing in hard science to incubate transformative technologies, ensuring strong intellectual property to protect these innovations, confronting well-defined problems that present measurable challenges, and recognizing market buy-in as an early indicator of demand and project suitability. Zoic Capital's portfolio comprises companies that they've invested in, incubated, or founded, showcasing their hands-on approach to fostering growth in their investments. The team, led by Managing Director Neal Mody, Partner Ian Eliason, Partner Adrian Berliner, and Venture Partner Shayan Bhattacharyya, consists of experienced professionals with diverse backgrounds spanning across the fields of health venture capital, technology, patent strategy, and scientific research. Mody, a tech startup veteran, and co-founder of several successful enterprises, lends his extensive experience to the strategic and operational guidance of portfolio companies. Eliason, who has been with the firm since its inception, is instrumental in investment analysis, firm operations, and has evaluated over 3,000 life sciences companies. Berliner's expertise in biotechnology and interdisciplinary technology sharpens Zoic's due diligence and the development of its investment strategies. Bhattacharyya, with a stronghold in diverse operational and investment roles, enhances the firm's global healthcare portfolio with his broad expertise. Zoic Capital invites engagement with innovators who are working on challenging and valuable problems, setting the stage for cooperation and growth in the field of life sciences.